We provide contract research and consultancy services to aid the development of novel therapeutics and diagnostics for Parkinsonâ€™s disease. We also offer a range of fine chemicals and reagents specific for use in pre-clinical PD modeling. Atuka Inc. comprises a group of Ph.D. qualified Scientists with considerable experience in the field of translation of therapeutic molecules for Parkinsonâ€™s disease. Atuka Ltd. was founded in 2003 by Dr. Jonathan Brotchie, an expert in the field of Parkinsonâ€™s disease. Dr Brotchie, along with Dr Hill and Mr Sefton, were co-founders of Atuka Inc., which was incorporated in 2011. Atuka operates over multiple sites in Canada and China and is affiliated with University Health Network which has an equity stake in Atuka.
Offices in :
56th Floor, Suite 5600 First Canadian Place 100 King Street West Toronto, Ontario, M5X 1C9